BioSpace News Archive

DENTSPLY SIRONA Inc., The Dental Solutions Company™, announced that the Company will host an investor conference call and live webcast on Thursday, August 6, 2020 at 8:00 am ET and send out an earnings press release earlier that morning.

The date under the “Expiration Date” column for the row associated with Batch Number 6122207 should read: 06/2021.

Aurinia Pharmaceuticals Inc. announced the pricing of its underwritten public offering of 13,333,334 common shares.

.Alexander Eggermont, MD, PhD, Chief Scientific Officer at the Princess Máxima Center and renowned expert in immunotherapy showcased the broad potential of BI-1206 in enhancing checkpoint inhibitors in solid cancers in a KOL event hosted by BioInvent on July 21.

T3 Pharmaceuticals AG announced the closing of its third financing round, raising over 25M CHF.

MC2 Therapeutics, a commercial stage pharmaceutical company developing a new standard of topical therapies for chronic inflammatory conditions, announced that the U.S. Food and Drug Administration has approved Wynzora® Cream for once-daily topical treatment of plaque psoriasis in adults 18 years of age or older.

Ascentage Pharma announced that the Phase Ib study of the company’s novel MDM2-p53 inhibitor candidate APG-115 as a single agent or in combinations for the treatment of Chinese patients with relapsed/refractory acute myeloid leukemia, or relapsed/progressed high/very high risk myelodysplastic syndrome has dosed its first patient in China.

Eargo, a medical device company on a mission to improve the quality of life of people with hearing loss, announced that CEO Christian Gormsen has won two 2020 Comparably Awards for the categories of “Best CEOs for Diversity” and “Best CEOs for Women.”

Vantage Orian 1.5T the Latest System in Company’s Portfolio with Access to Advanced intelligent Clear-IQ Engine (AiCE)

AlmirallShare launches its fifth call for proposals, aiming to establish partnerships to find new assets--new chemical entities, biologics and other advanced therapies--for the treatment of dermatological conditions